SCHEMBL4537527

SCHEMBL4537527

CCc1nc(C(N)CCC2CCN(C)CC2)ncc1-c1nc2c(C)c(F)ccc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4543946 0.91 HRH4 (0.66) HRH4
SCHEMBL4537534 0.85 HRH4 (0.50) HRH4
SCHEMBL2909049 0.80 HRH4 (0.83) HRH4
SCHEMBL4543952 0.76 HRH4 (0.57) HRH4
SCHEMBL605260 0.73 HRH4 (0.82) HRH4
SCHEMBL2906292 0.73 HRH4 (0.81) HRH4
SCHEMBL3950565 0.72 HRH4 (0.54) HRH4
SCHEMBL603807 0.72 HRH4 (1.00) HRH4
SCHEMBL2910187 0.72 HRH4 (1.00) HRH4
SCHEMBL603980 0.72 HRH4 (0.77) HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007752-A4 BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2009-04-22 EP disclosed
EP-2007752-A2 BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-12-31 EP disclosed
WO-2007117399-A2 BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-18 WO disclosed